WHO opens final negotiations on pathogen access-benefit sharing for pandemic treaty
Published · Updated
What happened
On 2026-06-14, WHO member-state negotiations entered a final phase on the PABS mechanism within the pandemic treaty process. The core dispute remains between countries seeking rapid, open pathogen-data sharing and countries demanding clearer, enforceable benefit-sharing obligations tied to resulting products and know-how.
Why it matters
PABS is operationally central to any pandemic accord because it affects whether countries will quickly share outbreak samples and genomic data in the next health emergency. A breakthrough could improve early detection and legal clarity for access to countermeasures; failure could weaken treaty credibility and leave major gaps in global outbreak response architecture.
Final negotiations began at the World Health Organization on the Pathogen Access and Benefit-Sharing (PABS) system, one of the last unresolved pillars of the pandemic treaty package. The talks focus on how countries and laboratories share pathogen samples and sequence data, and what binding benefits—such as access to vaccines, diagnostics, and treatments—must flow back in return. The outcome will shape both outbreak transparency incentives and future medical countermeasure allocation rules.
Watch for
WHO Intergovernmental Negotiating Body release of revised PABS bracket text or a clean negotiating draft by 2026-06-18 WHO Director-General Tedros Adhanom Ghebreyesus confirmation by 2026-06-18 of political convergence on benefit-sharing obligations for vaccines, therapeutics, and diagnostics European Commission or EU Council public readout by 2026-06-18 detailing the EU negotiating line on PABS benefit-sharing commitments No WHO notice by 2026-06-18 of an agreed PABS text for transmission to member states
Sources
- Newsroom · who.int
- WHO ringt um Pandemievertrag · tagesschau.de
Researched and written by AI from the sources listed, under published rules. How V³ Aware is made